Advanced Innovative Partners
ABOUT US
OUR PURPOSE
OUR PORTFOLIO
OUR TEAM
NEWS
CONTACT
AIP NEWS
Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Aromatic L-Amino Acid Decarboxylase.
Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Acute Lymphoblastic Leukemia
Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Acute Radiation Syndrome
Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Atypical Teratoid Rhabdoid Tumors
Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Diffuse Intrinsic Pontine Glioma
Advanced Innovative Partners Receives Orphan Dug and Rare Pediatric Disease Designation from the FDA for Hepatoblastoma
Advanced Innovative Partners Receives Orphan Dug and Rare Pediatric Disease Designation from the FDA for Lesch-Nyhan Syndrome
Advanced Innovative Partners Receives Orphan Drug and Rare Pediatric Disease Designation from the FDA for Medulloblastoma
About Us
Our Purpose
Our Portfolio
Our Team
News
Contact
© Copyright 2023 - All Rights Reserved
